{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:36:28Z","timestamp":1790811388554,"version":"4.1.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["XSGG2020001"],"award-info":[{"award-number":["XSGG2020001"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00415-025-13472-8","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:37:52Z","timestamp":1761147472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The development and emerging trends in Parkinson\u2019s disease from the perspective of mitochondrial dysfunction: a bibliometric analysis using CiteSpace"],"prefix":"10.1007","volume":"272","author":[{"given":"Yanzhi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-6214","authenticated-orcid":false,"given":"Yu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"13472_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet (London, England) 386:896\u2013912. https:\/\/doi.org\/10.1016\/s0140-6736(14)61393-3","journal-title":"Lancet (London, England)"},{"key":"13472_CR2","unstructured":"WHO (2023). Parkinson disease [Online]. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/parkinson-disease. Accessed 9 Aug 2023"},{"key":"13472_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet (London, England) 403:283\u2013292. https:\/\/doi.org\/10.1016\/s0140-6736(23)01419-8","journal-title":"Lancet (London, England)"},{"key":"13472_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01135-3","volume":"7","author":"F Lin","year":"2024","unstructured":"Lin F, Lin Y, Chen L, Huang T, Lin T, He J et al (2024) Association of physical activity pattern and risk of Parkinson\u2019s disease. NPJ Digit Med 7:137. https:\/\/doi.org\/10.1038\/s41746-024-01135-3","journal-title":"NPJ Digit Med"},{"key":"13472_CR5","doi-asserted-by":"publisher","first-page":"1600955","DOI":"10.3389\/fnut.2025.1600955","volume":"12","author":"R Zhang","year":"2025","unstructured":"Zhang R, Shu L, Zhu Q, Li N (2025) Adherence to a priori and a posteriori dietary patterns and risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. Front Nutr 12:1600955. https:\/\/doi.org\/10.3389\/fnut.2025.1600955","journal-title":"Front Nutr"},{"key":"13472_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102340","volume":"98","author":"S Afsheen","year":"2024","unstructured":"Afsheen S, Rehman AS, Jamal A, Khan N, Parvez S (2024) Understanding role of pesticides in development of Parkinson\u2019s disease: insights from Drosophila and rodent models. Ageing Res Rev 98:102340. https:\/\/doi.org\/10.1016\/j.arr.2024.102340","journal-title":"Ageing Res Rev"},{"key":"13472_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Movement Disorders 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Movement Disorders"},{"key":"13472_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13472_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, Group oBotNV (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov Disord 26:399\u2013406. https:\/\/doi.org\/10.1002\/mds.23462","journal-title":"Mov Disord"},{"key":"13472_CR10","unstructured":"NICE (2017). Parkinson\u2019s disease in adults. National Institute for Health and Care Excellence. https:\/\/www.nice.org.uk\/guidance\/ng71\/chapter\/Recommendations Accessed 19 July 2017."},{"key":"13472_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1212\/wnl.0000000000012868","volume":"97","author":"T Pringsheim","year":"2021","unstructured":"Pringsheim T, Day GS, Smith DB, Rae-Grant A, Licking N, Armstrong MJ et al (2021) Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN guideline subcommittee. Neurology 97:942\u2013957. https:\/\/doi.org\/10.1212\/wnl.0000000000012868","journal-title":"Neurology"},{"key":"13472_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","volume":"284","author":"Group PS","year":"2000","unstructured":"Group PS (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group Jama 284:1931\u20131938. https:\/\/doi.org\/10.1001\/jama.284.15.1931","journal-title":"Parkinson Study Group Jama"},{"key":"13472_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1586\/ern.11.75","volume":"11","author":"S Perez-Lloret","year":"2011","unstructured":"Perez-Lloret S, Ver\u00f3nica RM, Luca R, Rascol O (2011) Pramipexole for the treatment of early Parkinson\u2019s disease. Expert Rev Neurother 11:925\u2013935. https:\/\/doi.org\/10.1586\/ern.11.75","journal-title":"Expert Rev Neurother"},{"key":"13472_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495\u2013505","journal-title":"Ann Neurol"},{"key":"13472_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795. https:\/\/doi.org\/10.1038\/nature05292","journal-title":"Nature"},{"key":"13472_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science (New York, NY) 219:979\u2013980. https:\/\/doi.org\/10.1126\/science.6823561","journal-title":"Science (New York, NY)"},{"key":"13472_CR17","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36:2503\u20132508. https:\/\/doi.org\/10.1016\/0024-3205(85)90146-8","journal-title":"Life Sci"},{"key":"13472_CR18","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/j.1471-4159.1987.tb05737.x","volume":"48","author":"Y Mizuno","year":"1987","unstructured":"Mizuno Y, Sone N, Saitoh T (1987) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem 48:1787\u20131793. https:\/\/doi.org\/10.1111\/j.1471-4159.1987.tb05737.x","journal-title":"J Neurochem"},{"key":"13472_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0300-483x(88)90169-2","volume":"49","author":"TP Singer","year":"1988","unstructured":"Singer TP, Ramsay RR, McKeown K, Trevor A, Castagnoli NE Jr (1988) Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology 49:17\u201323. https:\/\/doi.org\/10.1016\/0300-483x(88)90169-2","journal-title":"Toxicology"},{"key":"13472_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1745691617718356","volume":"13","author":"P Kramer","year":"2018","unstructured":"Kramer P, Bressan P (2018) Our (Mother\u2019s) mitochondria and our mind. Perspect Psychol Sci 13:88\u2013100. https:\/\/doi.org\/10.1177\/1745691617718356","journal-title":"Perspect Psychol Sci"},{"key":"13472_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","volume":"21","author":"D Attwell","year":"2001","unstructured":"Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133\u20131145. https:\/\/doi.org\/10.1097\/00004647-200110000-00001","journal-title":"J Cereb Blood Flow Metab"},{"key":"13472_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.2000.80.1.315","volume":"80","author":"DG Nicholls","year":"2000","unstructured":"Nicholls DG, Budd SL (2000) Mitochondria and neuronal survival. Physiol Rev 80:315\u2013360. https:\/\/doi.org\/10.1152\/physrev.2000.80.1.315","journal-title":"Physiol Rev"},{"issue":"Suppl 1","key":"13472_CR23","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.0307513100","volume":"101","author":"C Chen","year":"2004","unstructured":"Chen C (2004) Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A 101(Suppl 1):5303\u20135310. https:\/\/doi.org\/10.1073\/pnas.0307513100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13472_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0378-8733(78)90021-7","volume":"1","author":"LC Freeman","year":"1978","unstructured":"Freeman LC (1978) Centrality in social networks conceptual clarification. Soc Networks 1:215\u2013239. https:\/\/doi.org\/10.1016\/0378-8733(78)90021-7","journal-title":"Soc Networks"},{"key":"13472_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"13472_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00415-022-11347-w","volume":"270","author":"F Baschieri","year":"2023","unstructured":"Baschieri F, Vitiello M, Cortelli P, Calandra-Buonaura G, Morgante F (2023) Autonomic dysfunction in progressive supranuclear palsy. J Neurol 270:109\u2013129. https:\/\/doi.org\/10.1007\/s00415-022-11347-w","journal-title":"J Neurol"},{"key":"13472_CR27","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37:1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"13472_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372:249\u2013263. https:\/\/doi.org\/10.1056\/NEJMra1311488","journal-title":"N Engl J Med"},{"key":"13472_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/mds.20083","volume":"19","author":"JC Zijlmans","year":"2004","unstructured":"Zijlmans JC, Daniel SE, Hughes AJ, R\u00e9v\u00e9sz T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630\u2013640. https:\/\/doi.org\/10.1002\/mds.20083","journal-title":"Mov Disord"},{"key":"13472_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00702-025-02960-w","volume":"132","author":"KA Jellinger","year":"2025","unstructured":"Jellinger KA (2025) Vascular parkinsonism: an update. J Neural Transm 132:899\u2013919. https:\/\/doi.org\/10.1007\/s00702-025-02960-w","journal-title":"J Neural Transm"},{"key":"13472_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/0022250X.2001.9990249","volume":"25","author":"U Brandes","year":"2001","unstructured":"Brandes U (2001) A faster algorithm for betweenness centrality. J Math Soc 25:163\u2013177","journal-title":"J Math Soc"},{"key":"13472_CR32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","volume":"57","author":"C Chen","year":"2006","unstructured":"Chen C (2006) CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol 57:359\u2013377. https:\/\/doi.org\/10.1002\/asi.20317","journal-title":"J Am Soc Inf Sci Technol"},{"key":"13472_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182413065","author":"P Cheng","year":"2021","unstructured":"Cheng P, Tang H, Dong Y, Liu K, Jiang P, Liu Y (2021) Knowledge mapping of research on land use change and food security: a visual analysis using CiteSpace and VOSviewer. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph182413065","journal-title":"Int J Environ Res Public Health"},{"key":"13472_CR34","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04779","volume":"441","author":"IE Clark","year":"2006","unstructured":"Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH et al (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:1162\u20131166. https:\/\/doi.org\/10.1038\/nature04779","journal-title":"Nature"},{"key":"13472_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608. https:\/\/doi.org\/10.1038\/33416","journal-title":"Nature"},{"key":"13472_CR36","doi-asserted-by":"publisher","first-page":"10793","DOI":"10.1073\/pnas.0602493103","volume":"103","author":"Y Yang","year":"2006","unstructured":"Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW et al (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 103:10793\u201310798. https:\/\/doi.org\/10.1073\/pnas.0602493103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13472_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nature04788","volume":"441","author":"J Park","year":"2006","unstructured":"Park J, Lee SB, Lee S, Kim Y, Song S, Kim S et al (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:1157\u20131161. https:\/\/doi.org\/10.1038\/nature04788","journal-title":"Nature"},{"key":"13472_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Primers 3:21. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"13472_CR39","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795\u2013803. https:\/\/doi.org\/10.1083\/jcb.200809125","journal-title":"J Cell Biol"},{"key":"13472_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J et al (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8:e1000298. https:\/\/doi.org\/10.1371\/journal.pbio.1000298","journal-title":"PLoS Biol"},{"key":"13472_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ (2015) The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85:257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"key":"13472_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler S, Holmstr\u00f6m KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ et al (2010) PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat Cell Biol 12:119\u2013131. https:\/\/doi.org\/10.1038\/ncb2012","journal-title":"Nat Cell Biol"},{"key":"13472_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11910-018-0829-3","volume":"18","author":"JS Park","year":"2018","unstructured":"Park JS, Davis RL, Sue CM (2018) Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep 18:11. https:\/\/doi.org\/10.1007\/s11910-018-0829-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"13472_CR44","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1073\/pnas.0709336105","volume":"105","author":"AC Poole","year":"2008","unstructured":"Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ (2008) The PINK1\/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A 105:1638\u20131643. https:\/\/doi.org\/10.1073\/pnas.0709336105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13472_CR45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ (2021) Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 46:329\u2013343. https:\/\/doi.org\/10.1016\/j.tibs.2020.11.007","journal-title":"Trends Biochem Sci"},{"key":"13472_CR46","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.nbd.2018.11.012","volume":"124","author":"X Reed","year":"2019","unstructured":"Reed X, Bandr\u00e9s-Ciga S, Blauwendraat C, Cookson MR (2019) The role of monogenic genes in idiopathic Parkinson\u2019s disease. Neurobiol Dis 124:230\u2013239. https:\/\/doi.org\/10.1016\/j.nbd.2018.11.012","journal-title":"Neurobiol Dis"},{"key":"13472_CR47","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","volume":"274","author":"MH Polymeropoulos","year":"1996","unstructured":"Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G et al (1996) Mapping of a gene for Parkinson\u2019s disease to chromosome 4q21-q23. Science (New York, NY) 274:1197\u20131199. https:\/\/doi.org\/10.1126\/science.274.5290.1197","journal-title":"Science (New York, NY)"},{"key":"13472_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.612476","author":"W Li","year":"2021","unstructured":"Li W, Fu Y, Halliday GM, Sue CM (2021) PARK genes link mitochondrial dysfunction and alpha-synuclein pathology in sporadic Parkinson\u2019s disease. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.612476","journal-title":"Front Cell Dev Biol"},{"key":"13472_CR49","doi-asserted-by":"publisher","first-page":"777","DOI":"10.4103\/1673-5374.322452","volume":"17","author":"S Eran","year":"2022","unstructured":"Eran S, Ronit PK (2022) APOE4 expression is associated with impaired autophagy and mitophagy in astrocytes. Neural Regen Res 17:777\u2013778. https:\/\/doi.org\/10.4103\/1673-5374.322452","journal-title":"Neural Regen Res"},{"key":"13472_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4103\/1673-5374.346472","volume":"18","author":"EF Fang","year":"2023","unstructured":"Fang EF, Anisimov A (2023) Turning up the NAD(+)-mitophagy axis to treat Alzheimer\u2019s disease. Neural Regen Res 18:319. https:\/\/doi.org\/10.4103\/1673-5374.346472","journal-title":"Neural Regen Res"},{"key":"13472_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12:9\u201314. https:\/\/doi.org\/10.1038\/nrm3028","journal-title":"Nat Rev Mol Cell Biol"},{"key":"13472_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.aquatox.2010.10.006","volume":"101","author":"VI Lushchak","year":"2011","unstructured":"Lushchak VI (2011) Environmentally induced oxidative stress in aquatic animals. Aquat Toxicol 101:13\u201330. https:\/\/doi.org\/10.1016\/j.aquatox.2010.10.006","journal-title":"Aquat Toxicol"},{"key":"13472_CR53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/jad-2011-111391","volume":"28","author":"VP Skulachev","year":"2012","unstructured":"Skulachev VP (2012) Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases. J Alzheimer\u2019s Dis 28:283\u2013289. https:\/\/doi.org\/10.3233\/jad-2011-111391","journal-title":"J Alzheimer\u2019s Dis"},{"key":"13472_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/428010","volume":"2012","author":"S Gandhi","year":"2012","unstructured":"Gandhi S, Abramov AY (2012) Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev 2012:428010. https:\/\/doi.org\/10.1155\/2012\/428010","journal-title":"Oxid Med Cell Longev"},{"key":"13472_CR55","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP (2004) Pathways towards and away from Alzheimer\u2019s disease. Nature 430:631\u2013639. https:\/\/doi.org\/10.1038\/nature02621","journal-title":"Nature"},{"key":"13472_CR56","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/s41593-019-0479-z","volume":"22","author":"C Fecher","year":"2019","unstructured":"Fecher C, Trov\u00f2 L, M\u00fcller SA, Snaidero N, Wettmarshausen J, Heink S et al (2019) Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity. Nat Neurosci 22:1731\u20131742. https:\/\/doi.org\/10.1038\/s41593-019-0479-z","journal-title":"Nat Neurosci"},{"key":"13472_CR57","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.bbagen.2014.02.013","volume":"1840","author":"N Plotegher","year":"2014","unstructured":"Plotegher N, Gratton E, Bubacco L (2014) Number and brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells. Biochim Biophys Acta 1840:2014\u20132024. https:\/\/doi.org\/10.1016\/j.bbagen.2014.02.013","journal-title":"Biochim Biophys Acta"},{"key":"13472_CR58","doi-asserted-by":"publisher","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","volume":"289","author":"ES Luth","year":"2014","unstructured":"Luth ES, Stavrovskaya IG, Bartels T, Kristal BS, Selkoe DJ (2014) Soluble, prefibrillar \u03b1-synuclein oligomers promote complex i-dependent, Ca2+-induced mitochondrial dysfunction. J Biol Chem 289:21490\u201321507. https:\/\/doi.org\/10.1074\/jbc.M113.545749","journal-title":"J Biol Chem"},{"key":"13472_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10599240801986215","volume":"13","author":"AS Dhillon","year":"2008","unstructured":"Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK, Nalbone JT et al (2008) Pesticide\/environmental exposures and Parkinson\u2019s disease in East Texas. J Agromedicine 13:37\u201348. https:\/\/doi.org\/10.1080\/10599240801986215","journal-title":"J Agromedicine"},{"key":"13472_CR60","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A et al (2012) Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2:898. https:\/\/doi.org\/10.1038\/srep00898","journal-title":"Sci Rep"},{"key":"13472_CR61","doi-asserted-by":"publisher","first-page":"23179","DOI":"10.1074\/jbc.M802223200","volume":"283","author":"N Sugeno","year":"2008","unstructured":"Sugeno N, Takeda A, Hasegawa T, Kobayashi M, Kikuchi A, Mori F et al (2008) Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death. J Biol Chem 283:23179\u201323188. https:\/\/doi.org\/10.1074\/jbc.M802223200","journal-title":"J Biol Chem"},{"key":"13472_CR62","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1111\/j.1742-4658.2007.06004.x","volume":"274","author":"P Srivastava","year":"2007","unstructured":"Srivastava P, Panda D (2007) Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. FEBS J 274:4788\u20134801. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06004.x","journal-title":"FEBS J"},{"key":"13472_CR63","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.neuropharm.2008.08.033","volume":"55","author":"AA Abdin","year":"2008","unstructured":"Abdin AA, Hamouda HE (2008) Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Neuropharmacology 55:1340\u20131346. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.08.033","journal-title":"Neuropharmacology"},{"key":"13472_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuint.2018.10.015","volume":"121","author":"N Serrano-Garc\u00eda","year":"2018","unstructured":"Serrano-Garc\u00eda N, Fern\u00e1ndez-Valverde F, Luis-Garcia ER, Granados-Rojas L, Ju\u00e1rez-Zepeda TE, Orozco-Su\u00e1rez SA et al (2018) Docosahexaenoic acid protection in a rotenone induced Parkinson\u2019s model: prevention of tubulin and synaptophysin loss, but no association with mitochondrial function. Neurochem Int 121:26\u201337. https:\/\/doi.org\/10.1016\/j.neuint.2018.10.015","journal-title":"Neurochem Int"},{"key":"13472_CR65","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","volume":"74","author":"M Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739\u2013789. https:\/\/doi.org\/10.1146\/annurev.biochem.73.011303.074134","journal-title":"Annu Rev Biochem"},{"key":"13472_CR66","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1093\/hmg\/ddi396","volume":"14","author":"WW Smith","year":"2005","unstructured":"Smith WW, Jiang H, Pei Z, Tanaka Y, Morita H, Sawa A et al (2005) Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum Mol Genet 14:3801\u20133811. https:\/\/doi.org\/10.1093\/hmg\/ddi396","journal-title":"Hum Mol Genet"},{"key":"13472_CR67","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","volume":"354","author":"JJ Hoozemans","year":"2007","unstructured":"Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W (2007) Activation of the unfolded protein response in Parkinson\u2019s disease. Biochem Biophys Res Commun 354:707\u2013711. https:\/\/doi.org\/10.1016\/j.bbrc.2007.01.043","journal-title":"Biochem Biophys Res Commun"},{"key":"13472_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature11910","volume":"495","author":"M Hamasaki","year":"2013","unstructured":"Hamasaki M, Furuta N, Matsuda A, Nezu A, Yamamoto A, Fujita N et al (2013) Autophagosomes form at ER-mitochondria contact sites. Nature 495:389\u2013393. https:\/\/doi.org\/10.1038\/nature11910","journal-title":"Nature"},{"key":"13472_CR69","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1207385","volume":"334","author":"JR Friedman","year":"2011","unstructured":"Friedman JR, Lackner LL, West M, DiBenedetto JR, Nunnari J, Voeltz GK (2011) ER tubules mark sites of mitochondrial division. Science (New York, NY) 334:358\u2013362. https:\/\/doi.org\/10.1126\/science.1207385","journal-title":"Science (New York, NY)"},{"key":"13472_CR70","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B et al (2021) Disruption of mitochondrial complex i induces progressive parkinsonism. Nature 599:650\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04059-0","journal-title":"Nature"},{"key":"13472_CR71","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/mds.21009","volume":"21","author":"R Frigerio","year":"2006","unstructured":"Frigerio R, Sanft KR, Grossardt BR, Peterson BJ, Elbaz A, Bower JH et al (2006) Chemical exposures and Parkinson\u2019s disease: a population-based case-control study. Mov Disord 21:1688\u20131692. https:\/\/doi.org\/10.1002\/mds.21009","journal-title":"Mov Disord"},{"key":"13472_CR72","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0510977103","volume":"103","author":"L Kussmaul","year":"2006","unstructured":"Kussmaul L, Hirst J (2006) The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc Natl Acad Sci U S A 103:7607\u20137612. https:\/\/doi.org\/10.1073\/pnas.0510977103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13472_CR73","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1074\/jbc.M708597200","volume":"283","author":"HM Cochem\u00e9","year":"2008","unstructured":"Cochem\u00e9 HM, Murphy MP (2008) Complex i is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283:1786\u20131798. https:\/\/doi.org\/10.1074\/jbc.M708597200","journal-title":"J Biol Chem"},{"key":"13472_CR74","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s002040050316","volume":"70","author":"T Tawara","year":"1996","unstructured":"Tawara T, Fukushima T, Hojo N, Isobe A, Shiwaku K, Setogawa T et al (1996) Effects of paraquat on mitochondrial electron transport system and catecholamine contents in rat brain. Arch Toxicol 70:585\u2013589. https:\/\/doi.org\/10.1007\/s002040050316","journal-title":"Arch Toxicol"},{"key":"13472_CR75","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","volume":"244","author":"JM McCord","year":"1969","unstructured":"McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049\u20136055","journal-title":"J Biol Chem"},{"key":"13472_CR76","doi-asserted-by":"publisher","first-page":"14267","DOI":"10.1002\/anie.201708573","volume":"56","author":"N Singh","year":"2017","unstructured":"Singh N, Savanur MA, Srivastava S, D\u2019Silva P, Mugesh G (2017) A redox modulatory Mn(3) O(4) nanozyme with multi-enzyme activity provides efficient cytoprotection to human cells in a Parkinson\u2019s disease model. Angew Chem Int Ed Engl 56:14267\u201314271. https:\/\/doi.org\/10.1002\/anie.201708573","journal-title":"Angew Chem Int Ed Engl"},{"key":"13472_CR77","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/jacs.8b11856","volume":"141","author":"C Hao","year":"2019","unstructured":"Hao C, Qu A, Xu L, Sun M, Zhang H, Xu C et al (2019) Chiral molecule-mediated porous Cu (x)O nanoparticle clusters with antioxidation activity for ameliorating Parkinson\u2019s disease. J Am Chem Soc 141:1091\u20131099. https:\/\/doi.org\/10.1021\/jacs.8b11856","journal-title":"J Am Chem Soc"},{"key":"13472_CR78","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/qjmed\/86.10.657","volume":"86","author":"PR Smith","year":"1993","unstructured":"Smith PR, Cooper JM, Govan GG, Harding AE, Schapira AH (1993) Smoking and mitochondrial function: a model for environmental toxins. Q J Med 86:657\u2013660. https:\/\/doi.org\/10.1093\/qjmed\/86.10.657","journal-title":"Q J Med"},{"key":"13472_CR79","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/sj.cdd.4402160","volume":"14","author":"AH Schapira","year":"2007","unstructured":"Schapira AH (2007) Mitochondrial dysfunction in Parkinson\u2019s disease. Cell Death Differ 14:1261\u20131266. https:\/\/doi.org\/10.1038\/sj.cdd.4402160","journal-title":"Cell Death Differ"},{"key":"13472_CR80","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.0905529106","volume":"106","author":"V Rhein","year":"2009","unstructured":"Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F et al (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice. Proc Natl Acad Sci U S A 106:20057\u201320062. https:\/\/doi.org\/10.1073\/pnas.0905529106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13472_CR81","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nn.3721","volume":"17","author":"H Yano","year":"2014","unstructured":"Yano H, Baranov SV, Baranova OV, Kim J, Pan Y, Yablonska S et al (2014) Inhibition of mitochondrial protein import by mutant huntingtin. Nat Neurosci 17:822\u2013831. https:\/\/doi.org\/10.1038\/nn.3721","journal-title":"Nat Neurosci"},{"key":"13472_CR82","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1093\/hmg\/ddt249","volume":"22","author":"S Pickles","year":"2013","unstructured":"Pickles S, Destroismaisons L, Peyrard SL, Cadot S, Rouleau GA, Brown RH Jr. et al (2013) Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum Mol Genet 22:3947\u20133959. https:\/\/doi.org\/10.1093\/hmg\/ddt249","journal-title":"Hum Mol Genet"},{"key":"13472_CR83","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","volume":"70","author":"E Floor","year":"1998","unstructured":"Floor E, Wetzel MG (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 70:268\u2013275. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70010268.x","journal-title":"J Neurochem"},{"key":"13472_CR84","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","volume":"193","author":"A Hald","year":"2005","unstructured":"Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson\u2019s disease: is there a causal link? Exp Neurol 193:279\u2013290. https:\/\/doi.org\/10.1016\/j.expneurol.2005.01.013","journal-title":"Exp Neurol"},{"key":"13472_CR85","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.bcp.2004.02.015","volume":"67","author":"D Ben-Shachar","year":"2004","unstructured":"Ben-Shachar D, Zuk R, Gazawi H, Ljubuncic P (2004) Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. Biochem Pharmacol 67:1965\u20131974. https:\/\/doi.org\/10.1016\/j.bcp.2004.02.015","journal-title":"Biochem Pharmacol"},{"key":"13472_CR86","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1073858402008003004","volume":"8","author":"TB Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Greenamyre JT (2002) Environment, mitochondria, and Parkinson\u2019s disease. Neuroscientist 8:192\u2013197. https:\/\/doi.org\/10.1177\/1073858402008003004","journal-title":"Neuroscientist"},{"key":"13472_CR87","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","volume":"102","author":"MA Eldeeb","year":"2022","unstructured":"Eldeeb MA, Thomas RA, Ragheb MA, Fallahi A, Fon EA (2022) Mitochondrial quality control in health and in Parkinson\u2019s disease. Physiol Rev 102:1721\u20131755. https:\/\/doi.org\/10.1152\/physrev.00041.2021","journal-title":"Physiol Rev"},{"key":"13472_CR88","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","volume":"26","author":"DP Narendra","year":"2024","unstructured":"Narendra DP, Youle RJ (2024) The role of PINK1-Parkin in mitochondrial quality control. Nat Cell Biol 26:1639\u20131651. https:\/\/doi.org\/10.1038\/s41556-024-01513-9","journal-title":"Nat Cell Biol"},{"key":"13472_CR89","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10571-021-01039-w","volume":"42","author":"XL Wang","year":"2022","unstructured":"Wang XL, Feng ST, Wang YT, Yuan YH, Li ZP, Chen NH et al (2022) Mitophagy, a form of selective autophagy, plays an essential role in mitochondrial dynamics of Parkinson\u2019s disease. Cell Mol Neurobiol 42:1321\u20131339. https:\/\/doi.org\/10.1007\/s10571-021-01039-w","journal-title":"Cell Mol Neurobiol"},{"key":"13472_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112399","author":"A Navarro-Romero","year":"2020","unstructured":"Navarro-Romero A, Montpey\u00f3 M, Martinez-Vicente M (2020) The emerging role of the lysosome in Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells9112399","journal-title":"Cells"},{"key":"13472_CR91","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B et al (2020) Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature 585:464\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2317-6","journal-title":"Nature"},{"key":"13472_CR92","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/jneurosci.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405\u20131410. https:\/\/doi.org\/10.1523\/jneurosci.4564-06.2007","journal-title":"J Neurosci"},{"key":"13472_CR93","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi JC, Hirth F (2018) Mechanisms of \u03b1-synuclein induced synaptopathy in Parkinson\u2019s disease. Front Neurosci 12:80. https:\/\/doi.org\/10.3389\/fnins.2018.00080","journal-title":"Front Neurosci"},{"key":"13472_CR94","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science (New York, NY) 294:1346\u20131349. https:\/\/doi.org\/10.1126\/science.1063522","journal-title":"Science (New York, NY)"},{"key":"13472_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.166","volume":"6","author":"AK Reeve","year":"2015","unstructured":"Reeve AK, Ludtmann MH, Angelova PR, Simcox EM, Horrocks MH, Klenerman D et al (2015) Aggregated \u03b1-synuclein and complex i deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis 6:e1820. https:\/\/doi.org\/10.1038\/cddis.2015.166","journal-title":"Cell Death Dis"},{"key":"13472_CR96","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1007\/s00018-017-2541-x","volume":"74","author":"V Tapias","year":"2017","unstructured":"Tapias V, Hu X, Luk KC, Sanders LH, Lee VM, Greenamyre JT (2017) Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production. Cell Mol life Sci 74:2851\u20132874. https:\/\/doi.org\/10.1007\/s00018-017-2541-x","journal-title":"Cell Mol life Sci"},{"key":"13472_CR97","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","volume":"9","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann MHR, Angelova PR, Horrocks MH, Choi ML, Rodrigues M, Baev AY et al (2018) \u0391-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun 9:2293. https:\/\/doi.org\/10.1038\/s41467-018-04422-2","journal-title":"Nat Commun"},{"key":"13472_CR98","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00401-017-1704-z","volume":"134","author":"S Paillusson","year":"2017","unstructured":"Paillusson S, Gomez-Suaga P, Stoica R, Little D, Gissen P, Devine MJ et al (2017) \u03b1-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca(2+) homeostasis and mitochondrial ATP production. Acta Neuropathol 134:129\u2013149. https:\/\/doi.org\/10.1007\/s00401-017-1704-z","journal-title":"Acta Neuropathol"},{"key":"13472_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L et al (2021) Targeting microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol 12:719807. https:\/\/doi.org\/10.3389\/fimmu.2021.719807","journal-title":"Front Immunol"},{"key":"13472_CR100","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","volume":"17","author":"Z Fan","year":"2020","unstructured":"Fan Z, Pan YT, Zhang ZY, Yang H, Yu SY, Zheng Y et al (2020) Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease. J Neuroinflamm 17:11. https:\/\/doi.org\/10.1186\/s12974-019-1670-6","journal-title":"J Neuroinflamm"},{"key":"13472_CR101","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah4066","author":"R Gordon","year":"2018","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S et al (2018) Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","journal-title":"Sci Transl Med"},{"key":"13472_CR102","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nrn3638","volume":"15","author":"JG Walsh","year":"2014","unstructured":"Walsh JG, Muruve DA, Power C (2014) Inflammasomes in the CNS. Nat Rev Neurosci 15:84\u201397. https:\/\/doi.org\/10.1038\/nrn3638","journal-title":"Nat Rev Neurosci"},{"key":"13472_CR103","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H et al (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535:153\u2013158. https:\/\/doi.org\/10.1038\/nature18629","journal-title":"Nature"},{"key":"13472_CR104","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","volume":"3","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A et al (2017) Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson\u2019s disease. NPJ Parkinsons Dis 3:30. https:\/\/doi.org\/10.1038\/s41531-017-0032-2","journal-title":"NPJ Parkinsons Dis"},{"key":"13472_CR105","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West AP, Shadel GS (2017) Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol 17:363\u2013375. https:\/\/doi.org\/10.1038\/nri.2017.21","journal-title":"Nat Rev Immunol"},{"key":"13472_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.720490","volume":"9","author":"A Bahat","year":"2021","unstructured":"Bahat A, MacVicar T, Langer T (2021) Metabolism and innate immunity meet at the mitochondria. Front Cell Dev Biol 9:720490. https:\/\/doi.org\/10.3389\/fcell.2021.720490","journal-title":"Front Cell Dev Biol"},{"key":"13472_CR107","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC et al (2011) Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12:222\u2013230. https:\/\/doi.org\/10.1038\/ni.1980","journal-title":"Nat Immunol"},{"key":"13472_CR108","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S et al (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36:401\u2013414. https:\/\/doi.org\/10.1016\/j.immuni.2012.01.009","journal-title":"Immunity"},{"key":"13472_CR109","doi-asserted-by":"publisher","first-page":"15514","DOI":"10.1073\/pnas.1414859111","volume":"111","author":"J Yu","year":"2014","unstructured":"Yu J, Nagasu H, Murakami T, Hoang H, Broderick L, Hoffman HM et al (2014) Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc Natl Acad Sci U S A 111:15514\u201315519. https:\/\/doi.org\/10.1073\/pnas.1414859111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13472_CR110","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12974-019-1668-0","volume":"16","author":"SH Su","year":"2019","unstructured":"Su SH, Wu YF, Lin Q, Wang DP, Hai J (2019) URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion. J Neuroinflammation 16:260. https:\/\/doi.org\/10.1186\/s12974-019-1668-0","journal-title":"J Neuroinflammation"},{"key":"13472_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111490","author":"A Scorziello","year":"2024","unstructured":"Scorziello A, Sirabella R, Sisalli MJ, Tufano M, Giaccio L, D\u2019Apolito E et al (2024) Mitochondrial dysfunction in parkinson\u2019s disease: a contribution to cognitive impairment? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252111490","journal-title":"Int J Mol Sci"},{"key":"13472_CR112","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/mds.26513","volume":"31","author":"AP Gatt","year":"2016","unstructured":"Gatt AP, Duncan OF, Attems J, Francis PT, Ballard CG, Bateman JM (2016) Dementia in Parkinson\u2019s disease is associated with enhanced mitochondrial complex I deficiency. Mov Disord 31:352\u2013359. https:\/\/doi.org\/10.1002\/mds.26513","journal-title":"Mov Disord"},{"key":"13472_CR113","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1042\/cs20190351","volume":"133","author":"A Manfredini","year":"2019","unstructured":"Manfredini A, Constantino L, Pinto MC, Michels M, Burger H, Kist LW et al (2019) Mitochondrial dysfunction is associated with long-term cognitive impairment in an animal sepsis model. Clin Sci 133:1993\u20132004. https:\/\/doi.org\/10.1042\/cs20190351","journal-title":"Clin Sci"},{"key":"13472_CR114","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4103\/1673-5374.382222","volume":"19","author":"W You","year":"2024","unstructured":"You W, Li Y, Liu K, Mi X, Li Y, Guo X et al (2024) Latest assessment methods for mitochondrial homeostasis in cognitive diseases. Neural Regen Res 19:754\u2013768. https:\/\/doi.org\/10.4103\/1673-5374.382222","journal-title":"Neural Regen Res"},{"key":"13472_CR115","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1038\/s41380-023-02251-4","volume":"28","author":"E Tresse","year":"2023","unstructured":"Tresse E, Marturia-Navarro J, Sew WQG, Cisquella-Serra M, Jaberi E, Riera-Ponsati L et al (2023) Mitochondrial DNA damage triggers spread of Parkinson\u2019s disease-like pathology. Mol Psychiatry 28:4902\u20134914. https:\/\/doi.org\/10.1038\/s41380-023-02251-4","journal-title":"Mol Psychiatry"},{"key":"13472_CR116","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1007\/s12035-021-02375-0","volume":"58","author":"Y Liang","year":"2021","unstructured":"Liang Y, Cui L, Gao J, Zhu M, Zhang Y, Zhang HL (2021) Gut microbial metabolites in Parkinson\u2019s disease: implications of mitochondrial dysfunction in the pathogenesis and treatment. Mol Neurobiol 58:3745\u20133758. https:\/\/doi.org\/10.1007\/s12035-021-02375-0","journal-title":"Mol Neurobiol"},{"key":"13472_CR117","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fphys.2018.00471","volume":"9","author":"SM Cardoso","year":"2018","unstructured":"Cardoso SM, Empadinhas N (2018) The microbiome-mitochondria dance in prodromal Parkinson\u2019s disease. Front Physiol 9:471. https:\/\/doi.org\/10.3389\/fphys.2018.00471","journal-title":"Front Physiol"},{"key":"13472_CR118","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-018-1055-2","volume":"15","author":"T Chunchai","year":"2018","unstructured":"Chunchai T, Thunapong W, Yasom S, Wanchai K, Eaimworawuthikul S, Metzler G et al (2018) Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats. J Neuroinflammation 15:11. https:\/\/doi.org\/10.1186\/s12974-018-1055-2","journal-title":"J Neuroinflammation"},{"key":"13472_CR119","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/s0140-6736(82)90820-0","volume":"2","author":"RT Ravenholt","year":"1982","unstructured":"Ravenholt RT, Foege WH (1982) 1918 influenza, encephalitis lethargica, parkinsonism. Lancet (London, England) 2:860\u2013864. https:\/\/doi.org\/10.1016\/s0140-6736(82)90820-0","journal-title":"Lancet (London, England)"},{"key":"13472_CR120","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1038\/ncomms5713","volume":"5","author":"T Yoshizumi","year":"2014","unstructured":"Yoshizumi T, Ichinohe T, Sasaki O, Otera H, Kawabata S-i, Mihara K et al (2014) Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity. Nat Commun 5:4713. https:\/\/doi.org\/10.1038\/ncomms5713","journal-title":"Nat Commun"},{"key":"13472_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101270","volume":"23","author":"M Moriyama","year":"2020","unstructured":"Moriyama M, Nagai M, Maruzuru Y, Koshiba T, Kawaguchi Y, Ichinohe T (2020) Influenza virus-induced oxidized DNA activates inflammasomes. iScience 23:101270. https:\/\/doi.org\/10.1016\/j.isci.2020.101270","journal-title":"iScience"},{"key":"13472_CR122","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1038\/s41467-019-12632-5","volume":"10","author":"M Moriyama","year":"2019","unstructured":"Moriyama M, Koshiba T, Ichinohe T (2019) Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses. Nat Commun 10:4624. https:\/\/doi.org\/10.1038\/s41467-019-12632-5","journal-title":"Nat Commun"},{"key":"13472_CR123","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-virology-111821-115754","volume":"10","author":"DE Campbell","year":"2023","unstructured":"Campbell DE, Li Y, Ingle H, Baldridge MT (2023) Impact of the microbiota on viral infections. Annu Rev Virol 10:371\u2013395. https:\/\/doi.org\/10.1146\/annurev-virology-111821-115754","journal-title":"Annu Rev Virol"},{"key":"13472_CR124","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41385-020-00361-8","volume":"14","author":"V Sencio","year":"2021","unstructured":"Sencio V, Machado MG, Trottein F (2021) The lung\u2013gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol 14:296\u2013304. https:\/\/doi.org\/10.1038\/s41385-020-00361-8","journal-title":"Mucosal Immunol"},{"key":"13472_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030740","author":"CT Hong","year":"2020","unstructured":"Hong CT, Chen KY, Wang W, Chiu JY, Wu D, Chao TY et al (2020) Insulin resistance promotes Parkinson\u2019s disease through aberrant expression of \u03b1-synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling. Cells. https:\/\/doi.org\/10.3390\/cells9030740","journal-title":"Cells"},{"key":"13472_CR126","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O et al (2011) PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson\u2019s disease. Cell 144:689\u2013702. https:\/\/doi.org\/10.1016\/j.cell.2011.02.010","journal-title":"Cell"},{"key":"13472_CR127","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T (2016) Insulin resistance and Parkinson\u2019s disease: a new target for disease modification? Prog Neurobiol 145:98\u2013120. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.10.001","journal-title":"Prog Neurobiol"},{"key":"13472_CR128","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson K-F, Subramanian A, Sihag S, Lehar J et al (2003) PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267\u2013273. https:\/\/doi.org\/10.1038\/ng1180","journal-title":"Nat Genet"},{"key":"13472_CR129","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1073\/pnas.1032913100","volume":"100","author":"ME Patti","year":"2003","unstructured":"Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:8466\u20138471. https:\/\/doi.org\/10.1073\/pnas.1032913100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13472_CR130","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2016.05.009","volume":"93","author":"A Siddiqui","year":"2016","unstructured":"Siddiqui A, Rane A, Rajagopalan S, Chinta SJ, Andersen JK (2016) Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson\u2019s disease are attenuated by restoration of PGC1alpha. Neurobiol Dis 93:115\u2013120. https:\/\/doi.org\/10.1016\/j.nbd.2016.05.009","journal-title":"Neurobiol Dis"},{"key":"13472_CR131","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/neuroglia5040026","volume":"5","author":"D Ghosh","year":"2024","unstructured":"Ghosh D, Kumar A (2024) Harnessing mitophagy for therapeutic advances in aging and chronic neurodegenerative diseases. Neuroglia 5:391\u2013409","journal-title":"Neuroglia"},{"key":"13472_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102667","volume":"104","author":"P Wen","year":"2025","unstructured":"Wen P, Sun Z, Gou F, Wang J, Fan Q, Zhao D et al (2025) Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders. Ageing Res Rev 104:102667. https:\/\/doi.org\/10.1016\/j.arr.2025.102667","journal-title":"Ageing Res Rev"},{"key":"13472_CR133","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/mds.23148","volume":"25","author":"BJ Snow","year":"2010","unstructured":"Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O\u2019Sullivan JD, Fung V et al (2010) A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease. Mov Disord 25:1670\u20131674. https:\/\/doi.org\/10.1002\/mds.23148","journal-title":"Mov Disord"},{"key":"13472_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24900-3","volume":"8","author":"J Beyrath","year":"2018","unstructured":"Beyrath J, Pellegrini M, Renkema H, Houben L, Pecheritsyna S, van Zandvoort P et al (2018) KH176 safeguards mitochondrial diseased cells from redox stress-induced cell death by interacting with the thioredoxin system\/peroxiredoxin enzyme machinery. Sci Rep 8:6577. https:\/\/doi.org\/10.1038\/s41598-018-24900-3","journal-title":"Sci Rep"},{"key":"13472_CR135","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/brain\/awae277","volume":"148","author":"J Smeitink","year":"2025","unstructured":"Smeitink J, van Es J, Bosman B, Janssen MCH, Klopstock T, Gorman G et al (2025) Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation. Brain 148:896\u2013907. https:\/\/doi.org\/10.1093\/brain\/awae277","journal-title":"Brain"},{"key":"13472_CR136","doi-asserted-by":"publisher","first-page":"29789","DOI":"10.1039\/d4ra05517a","volume":"14","author":"M Li","year":"2024","unstructured":"Li M, Kong D, Meng L, Wang Z, Bai Z, Wu G (2024) Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH(2)) derivatives as potent agents to ameliorate inflammation and increase mitochondrial ATP synthesis. RSC Adv 14:29789\u201329799. https:\/\/doi.org\/10.1039\/d4ra05517a","journal-title":"RSC Adv"},{"key":"13472_CR137","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/clpt.2014.174","volume":"96","author":"HH Szeto","year":"2014","unstructured":"Szeto HH, Birk AV (2014) Serendipity and the discovery of novel compounds that restore mitochondrial plasticity. Clin Pharmacol Ther 96:672\u2013683. https:\/\/doi.org\/10.1038\/clpt.2014.174","journal-title":"Clin Pharmacol Ther"},{"key":"13472_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26030944","author":"C Tung","year":"2025","unstructured":"Tung C, Varzideh F, Farroni E, Mone P, Kansakar U, Jankauskas SS et al (2025) Elamipretide: a review of its structure, mechanism of action, and therapeutic potential. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26030944","journal-title":"Int J Mol Sci"},{"key":"13472_CR139","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jtcvs.2020.10.151","volume":"162","author":"A Guariento","year":"2021","unstructured":"Guariento A, Piekarski BL, Doulamis IP, Blitzer D, Ferraro AM, Harrild DM et al (2021) Autologous mitochondrial transplantation for cardiogenic shock in pediatric patients following ischemia-reperfusion injury. J Thorac Cardiovasc Surg 162:992\u20131001. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.10.151","journal-title":"J Thorac Cardiovasc Surg"},{"key":"13472_CR140","doi-asserted-by":"publisher","DOI":"10.1177\/0271678x241305230","author":"M Walker","year":"2024","unstructured":"Walker M, Levitt MR, Federico EM, Miralles FJ, Levy SH, Lynne Prijoles K et al (2024) Autologous mitochondrial transplant for acute cerebral ischemia: Phase 1 trial results and review. J Cereb Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678x241305230","journal-title":"J Cereb Blood Flow Metab"},{"key":"13472_CR141","doi-asserted-by":"publisher","first-page":"10597","DOI":"10.1038\/s41598-021-90094-w","volume":"11","author":"J-C Chang","year":"2021","unstructured":"Chang J-C, Chao Y-C, Chang H-S, Wu Y-L, Chang H-J, Lin Y-S et al (2021) Intranasal delivery of mitochondria for treatment of Parkinson\u2019s Disease model rats lesioned with 6-hydroxydopamine. Sci Rep 11:10597. https:\/\/doi.org\/10.1038\/s41598-021-90094-w","journal-title":"Sci Rep"},{"key":"13472_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102522","volume":"101","author":"R Iorio","year":"2024","unstructured":"Iorio R, Petricca S, Di Emidio G, Falone S, Tatone C (2024) Mitochondrial extracellular vesicles (mitoEVs): emerging mediators of cell-to-cell communication in health, aging and age-related diseases. Ageing Res Rev 101:102522. https:\/\/doi.org\/10.1016\/j.arr.2024.102522","journal-title":"Ageing Res Rev"},{"key":"13472_CR143","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41434-023-00434-w","volume":"31","author":"S Eghbalsaied","year":"2024","unstructured":"Eghbalsaied S, Lawler C, Petersen B, Hajiyev RA, Bischoff SR, Frankenberg S (2024) CRISPR\/Cas9-mediated base editors and their prospects for mitochondrial genome engineering. Gene Ther 31:209\u2013223. https:\/\/doi.org\/10.1038\/s41434-023-00434-w","journal-title":"Gene Ther"},{"key":"13472_CR144","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cvr\/cvn098","volume":"79","author":"R Ventura-Clapier","year":"2008","unstructured":"Ventura-Clapier R, Garnier A, Veksler V (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res 79:208\u2013217. https:\/\/doi.org\/10.1093\/cvr\/cvn098","journal-title":"Cardiovasc Res"},{"key":"13472_CR145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0092-8674(00)80611-x","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V et al (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115\u2013124. https:\/\/doi.org\/10.1016\/s0092-8674(00)80611-x","journal-title":"Cell"},{"key":"13472_CR146","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1124\/pr.110.003905","volume":"64","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3 C, Auwerx J (2012) Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev 64:166\u2013187. https:\/\/doi.org\/10.1124\/pr.110.003905","journal-title":"Pharmacol Rev"},{"key":"13472_CR147","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P (2005) Nutrient control of glucose homeostasis through a complex of PGC-1\u03b1 and SIRT1. Nature 434:113\u2013118. https:\/\/doi.org\/10.1038\/nature03354","journal-title":"Nature"},{"key":"13472_CR148","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal B, D\u00f6lle C, Riemer F, Ma Y, Nido GS, Skeie GO et al (2022) The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease. Cell Metab 34:396-407.e396. https:\/\/doi.org\/10.1016\/j.cmet.2022.02.001","journal-title":"Cell Metab"},{"key":"13472_CR149","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3 C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y et al (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15:838\u2013847. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.022","journal-title":"Cell Metab"},{"key":"13472_CR150","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1038\/s41467-023-43514-6","volume":"14","author":"H Berven","year":"2023","unstructured":"Berven H, Kverneng S, Sheard E, S\u00f8gnen M, Af Geijerstam SA, Haugarvoll K et al (2023) NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson\u2019s disease. Nat Commun 14:7793. https:\/\/doi.org\/10.1038\/s41467-023-43514-6","journal-title":"Nat Commun"},{"key":"13472_CR151","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax8891","author":"A Jo","year":"2021","unstructured":"Jo A, Lee Y, Kam TI, Kang SU, Neifert S, Karuppagounder SS et al (2021) Paris farnesylation prevents neurodegeneration in models of Parkinson\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aax8891","journal-title":"Sci Transl Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13472-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13472-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13472-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:01:00Z","timestamp":1763128860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13472-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":151,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["13472"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13472-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"721"}}